Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous labetalol vs intravenous lidocaine for hemodynamic control and postoperative nausea and vomiting
IRCT20100102002963N30Phase 3Completed
- Sponsor
- Islamic Azad University, Yazd Branch
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of labetalol and lidocaine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Islamic Azad University, Yazd Branch. Primary endpoints: Hemodynamic variables and Postoperative nausea and vomiting. Started May 2021; status: completed.
02
Drugs
labetalollidocaine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20100102002963N30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100102002963N30.